>
Switch to:

PTC Therapeutics Inventory-to-Revenue

: 0.11 (As of Mar. 2022)
View and export this data going back to 2013. Start your Free Trial

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. PTC Therapeutics's Total Inventories for the quarter that ended in Mar. 2022 was $15.6 Mil. PTC Therapeutics's Revenue for the three months ended in Mar. 2022 was $148.7 Mil. PTC Therapeutics's Inventory-to-Revenue for the quarter that ended in Mar. 2022 was 0.11.

PTC Therapeutics's Inventory-to-Revenue for the quarter that ended in Mar. 2022 increased from Dec. 2021 (0.10) to Dec. 2021 (0.11)

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. PTC Therapeutics's Days Inventory for the three months ended in Mar. 2022 was 140.17.

Total Inventories can be measured by Days Sales of Inventory (DSI). PTC Therapeutics's days sales of inventory (DSI) for the three months ended in Mar. 2022 was 9.55.

Inventory Turnover measures how fast the company turns over its inventory within a year. PTC Therapeutics's Inventory Turnover for the quarter that ended in Mar. 2022 was 0.65.


PTC Therapeutics Inventory-to-Revenue Historical Data

The historical data trend for PTC Therapeutics's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PTC Therapeutics Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Inventory-to-Revenue
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.05 0.06 0.05 0.03

PTC Therapeutics Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Inventory-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.14 0.12 0.10 0.11

Competitive Comparison

For the Biotechnology subindustry, PTC Therapeutics's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

PTC Therapeutics Inventory-to-Revenue Distribution

For the Biotechnology industry and Healthcare sector, PTC Therapeutics's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where PTC Therapeutics's Inventory-to-Revenue falls into.



PTC Therapeutics Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

PTC Therapeutics's Inventory-to-Revenue for the fiscal year that ended in Dec. 2021 is calculated as

Inventory-to-Revenue (A: Dec. 2021 )
=Total Inventories / Revenue
=( (Total Inventories (A: Dec. 2020 ) + Total Inventories (A: Dec. 2021 )) / count ) / Revenue (A: Dec. 2021 )
=( (18.697 + 15.856) / 2 ) / 538.593
=17.2765 / 538.593
=0.03

PTC Therapeutics's Inventory-to-Revenue for the quarter that ended in Mar. 2022 is calculated as

Inventory-to-Revenue (Q: Mar. 2022 )
=Total Inventories / Revenue
=( (Total Inventories (Q: Dec. 2021 ) + Total Inventories (Q: Mar. 2022 )) / count ) / Revenue (Q: Mar. 2022 )
=( (15.856 + 15.281) / 2 ) / 148.735
=15.5685 / 148.735
=0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PTC Therapeutics  (NAS:PTCT) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

PTC Therapeutics's Days Inventory for the three months ended in Mar. 2022 is calculated as:

Days Inventory=Total Inventories (Q: Mar. 2022 )/Cost of Goods Sold (Q: Mar. 2022 )*Days in Period
=15.5685/10.135*365 / 4
=140.17

2. Total Inventories can be measured by Days Sales of Inventory (DSI).

PTC Therapeutics's Days Sales of Inventory for the three months ended in Mar. 2022 is

Days Sales of Inventory (DSI)=Total Inventories (Q: Mar. 2022 )/Revenue (Q: Mar. 2022 )*Days in Period
=15.5685/148.735*365 / 4
=9.55

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

PTC Therapeutics's Inventory Turnover for the quarter that ended in Mar. 2022 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Mar. 2022 ) / Total Inventories (Q: Mar. 2022 )
=10.135 / 15.5685
=0.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PTC Therapeutics Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of PTC Therapeutics's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


PTC Therapeutics Business Description

PTC Therapeutics logo
Industry
Healthcare » Biotechnology NAICS : 325412 SIC : 2834
Traded in Other Exchanges
Address
100 Corporate Court, South Plainfield, NJ, USA, 07080
PTC Therapeutics Inc is a global biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when a RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.
Executives
Southwell David P director C/O INOTEK PHARMACEUTICALS CORPORATION 91 HARTWELL AVENUE LEXINGTON MA 02421
Jacobson Allan Steven director PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Peltz Stuart Walter director, officer: Chief Executive Officer PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Utter Christine Marie officer: SVP, Finance & CAO C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Boulding Mark Elliott officer: Exec. VP and CLO C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Hill Emily Luisa officer: Chief Financial Officer C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Svoronos Dawn director C/O MEDIVATION, INC. 525 MARKET ST., 36TH FLOOR SAN FRANCISCO CA 94105
Pauwels Eric officer: Chief Business Officer 550 HILLS DRIVE BEDMINSTER NJ 07921
Klein Matthew B. officer: Chief Development Officer C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Schmertzler Michael director 1300 VALLEY ROAD NEW CANAAN CT 06840
Souza Marcio officer: Chief Operating Officer C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Almstead Neil Gregory officer: Chief Technical Ops Officer C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Reeve Emma director C/O PAREXEL INTERNATIONAL CORPORATION 195 WEST STREET WALTHAM MA 02451
Steele Glenn Jr Md Phd director 250 TECHNOLOGY PARK LAKE MARY FL 32746-6232
Zeldis Jerome B director 8767 E. VIA DE VENTURA, SUITE 190 SCOTTSDALE AZ 85258

PTC Therapeutics Headlines

Other Sources

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)